News
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
25 Apr 24
Needham Reiterates Buy on Liquidia, Maintains $28 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
The Analyst Landscape: 5 Takes On Liquidia
1 Apr 24
Analyst Ratings
Needham Reiterates Buy on Liquidia, Maintains $28 Price Target
1 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
27 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
10 Health Care Stocks Whale Activity In Today's Session
18 Mar 24
Options
HC Wainwright & Co. Maintains Buy on Liquidia, Raises Price Target to $32
14 Mar 24
News, Price Target, Analyst Ratings
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
14 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Unveiling 6 Analyst Insights On Liquidia
13 Mar 24
Analyst Ratings
Needham Maintains Buy on Liquidia, Maintains $28 Price Target
13 Mar 24
News, Price Target, Analyst Ratings
Earnings Scheduled For March 13, 2024
13 Mar 24
Earnings
Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings
13 Mar 24
Earnings
Liquidia FY GAAP EPS $(1.21) Misses $(1.02) Estimate, Sales $17.49M Miss $17.69M Estimate
13 Mar 24
Earnings, News
Liquidia Earnings Preview
12 Mar 24
Earnings
United Therapeutics Filed Motion In U.S. District Court For The District Of Delaware For Preliminary Injunction In Its Patent Litigation With Liquidia Technologies' Efforts To Seek FDA Approval For PH-ILD For Its Inhaled Treprostinil Product-8K
27 Feb 24
Biotech, News, Health Care, Legal, General
Needham Reiterates Buy on Liquidia, Maintains $28 Price Target
21 Feb 24
News, Price Target, Reiteration, Analyst Ratings
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
21 Feb 24
Biotech, Earnings, Large Cap, News, Health Care, FDA, Legal, General
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
12 Feb 24
Analyst Color, News, Upgrades, Price Target, Small Cap, Top Stories, Analyst Ratings, Movers, Trading Ideas
Press releases
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
2 Apr 24
News, Press Releases
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
1 Apr 24
Analyst Ratings, Press Releases
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
13 Mar 24
Earnings, Press Releases
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
6 Mar 24
News, Press Releases
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
30 Jan 24
News, Press Releases